Cox Capital Management’s Elevance Health ELV Stock Holding History

Cox Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,653	Closed	-$1.3M	–	70
2022 Q1	$1.3M	Sell	2,653 -2,380	-47%	-$1.09M	0.82%	50
2021 Q4	$2.33M	Buy	5,033 +155	+3%	+$65.2K	1.38%	36
2021 Q3	$1.82M	Buy	4,878 +71	+1%	+$27K	1.23%	43
2021 Q2	$1.83M	Buy	4,807 +207	+5%	+$79.1K	1.23%	42
2021 Q1	$1.65M	Sell	4,600 -71	-2%	-$22.8K	1.14%	42
2020 Q4	$1.5M	Buy	4,671 +160	+4%	+$49.1K	1.14%	43
2020 Q3	$1.21M	Buy	4,511 +1,968	+77%	+$530K	1.07%	43
2020 Q2	$669K	Buy	2,543 +6	+0.2%	+$1.6K	0.66%	63
2020 Q1	$766K	Hold	2,537	–	–	0.67%	57
2019 Q4	$766K	Buy	2,537 +10	+0.4%	+$2.75K	0.7%	57
2019 Q3	$607K	Buy	2,527 +103	+4%	+$28.2K	0.59%	60
2019 Q2	$684K	Buy	2,424 +74	+3%	+$20.2K	0.69%	56
2019 Q1	$674K	Buy	2,350 +12	+0.5%	+$3.47K	0.73%	53
2018 Q4	$621K	Buy	+2,338	New	+$643K	0.73%	51

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Cox Capital Management's ELV Position: Q2 2022 in Review

Cox Capital Management sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 2,653 shares — an estimated $1.3M sold.

Cox Capital Management first reported a position in ELV in Q4 2018 and held it in 14 quarters. The position peaked at $2.33M in Q4 2021. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

Cox Capital Management reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
Cox Capital Management sold 2,653 Elevance Health shares in Q2 2022, an estimated $1.3M.
Cox Capital Management first reported a position in Elevance Health in Q4 2018 and held it in 14 quarters.
Cox Capital Management's Elevance Health position peaked at $2.33M in Q4 2021.
1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Cox Capital Management's 13F filing for Q2 2022, filed 8 Jul 2022.